REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Especializado Innovalab Sas (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio Clinico Especializado Innovalab Sas Profile Updated: April 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Laboratorio Clinico Especializado Innovalab Sas is an enterprise in Colombia, with the main office in El Espinal. The company operates in the Diagnostic Imaging Centers industry. Laboratorio Clinico Especializado Innovalab Sas was incorporated on May 06, 2013. From the latest financial highlights, Laboratorio Clinico Especializado Innovalab Sas reported a net sales revenue drop of 12.42% in 2025. Its’ total assets recorded a growth of 0.76%. The net profit margin of Laboratorio Clinico Especializado Innovalab Sas decreased by 4.46% in 2025.

Headquarters
Cr 5 10 69 Brr Centro
El Espinal; Tolima;

Contact Details: Purchase the Laboratorio Clinico Especializado Innovalab Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Laboratorio Clinico Especializado Innovalab Sas report to view the information.
Financial Auditors:
Purchase the Laboratorio Clinico Especializado Innovalab Sas report to view the information.
Incorporation Date:
May 06, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Clinico Especializado Innovalab Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-12.42%
Total Operating Revenue
-12.42%
Operating Profit
-34.91%
EBITDA
-45.06%
Net Profit/Loss for the Period
-52.9%
Total Assets
0.76%
Total Equity
9.73%
Operating Profit Margin
-4.64%
Net Profit Margin
-4.46%
Return on Equity (ROE)
-11.79%
Debt / Equity
0.71%
Quick Ratio
0.39%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?